HKSE - Delayed Quote HKD

CHANGMAO BIO (0954.HK)

0.290
+0.010
+(3.57%)
At close: May 8 at 3:59:20 PM GMT+8
Loading Chart for 0954.HK
  • Previous Close 0.280
  • Open 0.295
  • Bid 0.285 x --
  • Ask 0.315 x --
  • Day's Range 0.290 - 0.295
  • 52 Week Range 0.255 - 0.500
  • Volume 244,000
  • Avg. Volume 348,813
  • Market Cap (intraday) 148.316M
  • Beta (5Y Monthly) 0.56
  • PE Ratio (TTM) --
  • EPS (TTM) -0.140
  • Earnings Date Mar 24, 2025 - Mar 28, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date May 22, 2023
  • 1y Target Est --

Changmao Biochemical Engineering Company Limited, together with its subsidiaries, produces and sells organic acids for food additive, chemical, and pharmaceutical industries in Mainland China, Europe, the Asia Pacific, America, and internationally. The company offers fumaric acid, maleic acid, L-malic acid, D-malic acid, DL-malic acid, L(+)-tartaric acid, D(-)-tartaric acid, DL-tartaric acid, L-aspartic acid, and aspartame that are used as food additives, medical intermediaries, pharmaceutical adjuvant, and active pharmaceutical ingredient, etc. It is also involved in the research and development of medicine and nutraceutical products; trading of organic acids; and property holding activities. Changmao Biochemical Engineering Company Limited was founded in 1992 and is headquartered in Changzhou City, the People's Republic of China.

changmaobio.todayir.com

571

Full Time Employees

December 31

Fiscal Year Ends

Recent News: 0954.HK

View More

Performance Overview: 0954.HK

Trailing total returns as of 5/9/2025, which may include dividends or other distributions. Benchmark is HANG SENG INDEX (^HSI) .

YTD Return

0954.HK
27.50%
HANG SENG INDEX (^HSI)
14.00%

1-Year Return

0954.HK
32.56%
HANG SENG INDEX (^HSI)
23.36%

3-Year Return

0954.HK
53.66%
HANG SENG INDEX (^HSI)
14.33%

5-Year Return

0954.HK
51.29%
HANG SENG INDEX (^HSI)
5.62%

Compare To: 0954.HK

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 0954.HK

View More

Valuation Measures

Annual
As of 5/8/2025
  • Market Cap

    153.61M

  • Enterprise Value

    649.34M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.24

  • Price/Book (mrq)

    0.25

  • Enterprise Value/Revenue

    1.03

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -11.67%

  • Return on Assets (ttm)

    -2.83%

  • Return on Equity (ttm)

    -11.05%

  • Revenue (ttm)

    584.79M

  • Net Income Avi to Common (ttm)

    -68.24M

  • Diluted EPS (ttm)

    -0.140

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    74.56M

  • Total Debt/Equity (mrq)

    91.91%

  • Levered Free Cash Flow (ttm)

    -36.14M

Research Analysis: 0954.HK

View More

Company Insights: 0954.HK

Research Reports: 0954.HK

View More

People Also Watch